Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Comment by RedDeerMoneymanon Apr 14, 2015 11:54pm
81 Views
Post# 23630488

RE:Bought some more...

RE:Bought some more...
Thanks for sharing capitalgain for all the new people who have and will be coming aboard shortly. TWO REALLY BIG POINTS TO MENTION SINCE THE ARTICLE ARE, THE HEALTH CANADA EXEMPTION FOR USE OF CANNIBINOIDS. THE RECENT MITACS GRANT FOR CHRONIC OROFACIAL PAIN. Also good to mention that INMED has applied for two additional grants for pipelines yet to be announced. They noted in a recent newscast that their funded for the current year for the current pipelines announced, and are now preparing for expansion of the additional pipelines, HUNTINGTON'S DISEASE BEING ONE OF THE BIG ONES. Yes I own alot of shares in this company have been buying them regularly for the past five months. I believe strongly in what Craig and the team are doing as some of their progressions are going to help people I'm very close to. I'm not going to pump this stock as some may think I may be doing, I'm a very patient person whom knows this stock is going to sell itself once the team has proven their PATENTED IDP process works to the world. There is going to be a few more ups and downs before the real news is announced that people want to hear before this stock takes off. SO ENJOY BUYING WHILE THEY ARE STILL CHEAP, I WILL BE HONEST I DID ENJOY BUYING THEM A LOT MORE WHEN THEY WERE 10 CENTS LOL ALL THE BEST TO EVERYONE GOING TO BEA GOOD YEAR ONCE THEY ANNOUNCE SOME DEALS WITH BIGGER PHARMACEUTICAL COMPANIES. CHEERS ALL....
Bullboard Posts